King & Spalding advised Linden Capital Partners (“Linden”) on its acquisition of Solara Medical Supplies, LLC (“Solara”) – a deal that closed at the end of May. Solara, which began operations in 2002 and is headquartered in Chula Vista, California, is a leading direct-to-patient supplier of advanced diabetic devices, including continuous glucose monitors and insulin pumps. Linden identified Solara because of its expansive operations, potential for growth, and commitment to patient, manufacturers, and payors service. King & Spalding provided regulatory and compliance guidance to Linden, advising on deal structure and regulatory pitfalls and aiding a seamless transition as Linden assumed control of Solara’s operations. Solara serves patients nationwide from its locations in Alabama, California, Michigan, and Texas, and its operations involve hundreds of licenses, certificates, permits, and registrations across the country.